Moffitt's Doris K. Hansen, MD, Finds Patients Taking Daratumumab Frontline Combo in Multiple Myeloma Had Longer Time to Next Treatment.

Autor: Sava, Jordyn
Zdroj: American Journal of Managed Care. 2023 Special Issue, p17-18. 2p.
Databáze: Academic Search Ultimate